GL1X · GenesisL1 explorer

Research workbench

CDK6 in complex with CPD24 N-(5-(6-ethyl-2,6-DIAZASPIRO[3.3]HEPTAN-2- YL)PYRIDIN-2-yl)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H- PYRAZOLO[1,5-A]AZEPIN-3-YL)PYRIMIDIN-2-amine

Analyse CDK6 in complex with CPD24 N-(5-(6-ethyl-2,6-DIAZASPIRO[3.3]HEPTAN-2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6OQO
Type
protein
Length
269 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclin-dependent kinase 6
EC
2.7.11.22
UniProt
Q00534
Ligands
N1J
Pockets
2 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclin-dependent kinase 6 (EC 2.7.11.22)protein26938% helix, 17% strandQ00534

Ligands and binding sites

  • N1J · N-[5-(6-ethyl-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-2-yl]-5-fluoro-4-[(4R)-4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl]pyrimidin-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11880.640.8421N1J
2840.340.7417empty

Compared structures

  • 6OQO · CDK6 in complex with Cpd24 N-(5-(6-ethyl-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-2-yl)-5-fl… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q00534 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 6 (Q00534) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.